EXHIBIT 4.9


 


DESCRIPTION OF CAPITAL STOCK


 


Our authorized capital stock consists of 250,000,000
shares of common stock, $0.001 par value per share, and 25,000,000 shares of blank check preferred stock, $0.001 par value per share.
As of March 31, 2022, there are 113,187,898 shares of common stock and 0 shares of preferred stock outstanding.


 


This description is intended as a summary, and is
qualified in its entirety by reference to our amended and restated articles of incorporation and amended and restated by-laws, which are
filed, or incorporated by reference, as exhibits to our filings with the Securities and Exchange Commission.


 


Common Stock


 


Holders of our common stock are entitled to one vote
for each share held of record on all matters submitted to a vote of the stockholders, and do not have cumulative voting rights. Subject
to preferences that may be applicable to any outstanding shares of preferred stock, holders of common stock are entitled to receive ratably
such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available for dividend payments.
All outstanding, shares of common stock are fully paid and nonassessable. The holders of common stock have no preferences or rights of
cumulative voting, conversion, or pre-emptive or other subscription rights. There are no redemption or sinking fund provisions applicable
to the common stock. In the event of any liquidation, dissolution or winding-up of our affairs, holders of common stock will be entitled
to share ratably in any of our assets remaining after payment or provision for payment of all of our debts and obligations and after liquidation
payments to holders of outstanding shares of preferred stock, if any.


 


Warrants


 


November 2020 


 


The following is a summary of certain terms and provisions
of warrants issued in November 2020 (the “Warrants”).


 


The Warrants entitle the registered holder to purchase
one share of our common stock at a price equal to $9.80 per share, subject to adjustment as discussed below, immediately following the
issuance of such warrant and terminating at 5:00 p.m., New York City time, on November 27, 2023.


 


The exercise price and number of shares of common
stock issuable upon exercise of the Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization,
reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of common stock at prices below its
exercise price.


 


Exercisability. The Warrants are exercisable at any
time after their original issuance and at any time up to the date that is three (3) years after their original issuance. The warrants
may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the Company, with the
exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise
price, by certified or official bank check payable to us, for the number of Warrants being exercised.


 


Exercise Limitation. A holder may not exercise any
portion of a Warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would
own more than 4.99% of the outstanding common stock after exercise, as such percentage ownership is determined in accordance with the
terms of the Warrant, except that upon prior notice from the holder to us, the holder may waive such limitation up to a percentage not
in excess of 9.99%.


 


Exercise Price. The exercise price per whole share
of common stock purchasable upon exercise of the Warrants is $9.80 per share. The exercise price is subject to appropriate adjustment
in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting
our common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.


 




    	 



    	 



    

 


Fractional Shares. No fractional shares of common
stock will be issued upon exercise of the Warrants. If, upon exercise of the Warrant, a holder would be entitled to receive a fractional
interest in a share, we will, upon exercise, pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied
by the exercise price. If multiple Warrants are exercised by the holder at the same time, we shall pay a cash adjustment in respect of
such final fraction in an amount equal to such fraction multiplied by the exercise price.


 


Transferability. Subject to applicable laws, and the
restrictions set forth under the Form of Warrant, the Warrants shall not be offered for sale, sold, transferred or assigned for one hundred
eighty (180) days following the Effective Date, the lock-up period.


 


Fundamental Transactions. In the event of a fundamental
transaction, as described in the Warrants and generally including any reorganization, recapitalization or reclassification of our common
stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with
or into another person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial
owner of 50% of the voting power represented by our outstanding common stock, the holders of the Warrants will be entitled to receive
the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately
prior to such fundamental transaction.


 


Rights as a Stockholder. The Warrant holders do not
have the rights or privileges of holders of common stock or any voting rights until they exercise their Warrants and receive shares of
common stock. After the issuance of shares of common stock upon exercise of the Warrants, each holder will be entitled to one vote for
each share held of record on all matters to be voted on by stockholders.


 


May 2021 


 


The following is a summary of certain terms and provisions
of warrants issued in May 2021.


 


Each Series A Warrant entitles the registered holder
to purchase one share of Common Stock at a price equal to $5.07 per share, subject to adjustment as discussed below, terminating at 5:00
p.m., New York City time, on the fifth (5th) anniversary of the date of issuance. No fractional warrants will be issued and only whole
warrants are exercisable. The exercise price and number of shares of Common Stock issuable upon exercise of the Series A Warrants may
be adjusted in certain circumstances, including in the event of a stock dividend, extraordinary dividend on or recapitalization, reorganization,
merger or consolidation. If the Company fails to maintain a current prospectus or prospectus relating to the Common Stock issuable upon
the exercise of the Series A Warrants, holders may exercise their Series A Warrants on a “cashless” basis pursuant to a formula
set forth in the terms of the Series A Warrants. If at any time the closing price per share of the Common Stock shall exceed 300% of the
exercise price then in effect for five consecutive trading days on each of which the daily dollar volume of the Common Stock equals or
exceeds $5,000,000, the Company, at its option, may redeem the Series A Warrants, in whole or in part, at a price of $0.001 per share
(subject to adjustment as provided therein).


 


Each Series B Warrant entitles the holder thereof
to purchase one-half of a share of Common Stock at an exercise price of $6.59 per whole share, subject to adjustment as discussed below,
terminating at 5:00 p.m., New York City time, on the fifth (5th) anniversary of the date of issuance. No fractional warrants will be issued
and only whole warrants are exercisable. The exercise price and number of shares of Common Stock issuable upon exercise of a whole Series
B Warrant may be adjusted in certain circumstances, including in the event of a stock dividend, extraordinary dividend on or recapitalization,
reorganization, merger or consolidation. If the Company fails to maintain a current prospectus or prospectus relating to the Common Stock
issuable upon the exercise of the Series B Warrants, holders may exercise their Series B warrants on a “cashless” basis pursuant
to a formula set forth in the terms of the Series B Warrants. If at any time the closing price per share of the Common Stock shall exceed
300% of the exercise price then in effect for five consecutive trading days on each of which the daily dollar volume of the Common Stock
equals or exceeds $5,000,000, the Company, at its option, may redeem the Series B Warrants, in whole or in part, at a price of $0.001
per share (subject to adjustment as provided therein).


 


Warrant holders, subject to limited exceptions, cannot
exercise their warrants to the extent that, after giving effect to such exercise, the holder (together with its affiliates) would beneficially
own in excess of 4.99% (or, at the election of the purchaser, 9.99%; subject to increase at the option of the holder to 9.99% upon 61
days’ prior written notice) of the Company’s Common Stock outstanding immediately after giving effect to the exercise.


 


Preferred Stock


 


Our certificate of incorporation authorizes our board
of directors to issue 25,000,000 Preferred Stock, par value $0.001 per share and to fix the rights, preferences, privileges and restrictions,
including voting rights, of these shares, without further stockholder approval. Our Board of Directors has the authority, without further
stockholder authorization, to issue from time to time shares of preferred stock in one or more series and to fix the terms, limitations,
relative rights and preferences and variations of each series. Currently there are no outstanding shares of preferred stock.